A comprehensive biological insight of trinuclear copper(ii)–tin(iv) chemotherapeutic anticancer drug entity: in vitro cytotoxicity and in vivo systemic toxicity studies-Reference-Cited by-同舟云学术

A comprehensive biological insight of trinuclear copper(ii)–tin(iv) chemotherapeutic anticancer drug entity: in vitro cytotoxicity and in vivo systemic toxicity studies

Published:2014-05-09 Issue:8 Volume:6 Page:1469
ISSN:1756-5901
Container-title:Metallomics
language:en
Short-container-title:Metallomics

Author:

Zaidi Yusra,Arjmand Farukh,Zaidi Nida,Usmani Jawed Ahmad,Zubair Haseeb,Akhtar Kafil,Hossain Mobarak,Shadab G. G. H. A.

Publisher

Oxford University Press (OUP)

Subject

Metals and Alloys,Biochemistry,Biomaterials,Biophysics,Chemistry (miscellaneous)

Link

http://pubs.rsc.org/en/content/articlepdf/2014/MT/C4MT00035H

Reference44 articles.

1. Platinum Compounds: a New Class of Potent Antitumour Agents

2. New trends for metal complexes with anticancer activity

3. The resurgence of platinum-based cancer chemotherapy

4. Molecular mechanisms of resistance and toxicity associated with platinating agents

5. Pre-treatment with cardamonin protects against cisplatin-induced nephrotoxicity in rats: Impact on NOX-1, inflammation and apoptosis

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cu(bta)(1,10-phen)ClO4 copper complex modulates the carcinogenicity of carboplatin in somatic cells of Drosophila melanogaster;Genetics and Molecular Biology;2024

2. Recent progress in the role of endogenous metal ions in doxorubicin-induced cardiotoxicity;Frontiers in Pharmacology;2023-12-08

3. Progress of Metal‐Based Anticancer Chemotherapeutic Agents in Last two Decades and their Comprehensive Biological (DNA/RNA Binding, Cleavage and Cytotoxicity Activity) Studies;The Chemical Record;2023-02-10

4. Targeted therapy of non-small cell lung cancer and liver cancer: functional nanocarriers for the delivery of cisplatin and tissue factor pathway inhibitor-2;Chemotherapy;2022-11-03

5. Recent update on application of dihydromyricetin in metabolic related diseases;Biomedicine & Pharmacotherapy;2022-04